Lumbrokinase vs Nattokinase vs Serrapeptase [Benefits, Side Effects]

Summary

This video delves into the potential benefits and limitations of natural enzymes like nattokinase, serrapeptase, and lumbrokinase in promoting cardiovascular health and reducing blood clots. It reviews various studies, highlighting their effectiveness, possible side effects, and recommended dosages. While these enzymes show promise, particularly in reducing inflammation and improving blood flow, the clinical evidence is still not robust enough to make definitive recommendations. The video also cautions about interactions with blood-thinning medications and suggests consulting with a healthcare provider before use. Viewers are encouraged to share their experiences and insights.

Takeaways

• 😀 Nattokinase is primarily a thrombolytic agent, which means it can help dissolve blood clots, with some studies suggesting significant benefits in heart health.
• 😀 Serrapeptase is mainly used for pain relief and reducing inflammation, not for thinning blood, though it can have some impact on clotting.
• 😀 Clinical studies on Nattokinase show mixed results: some find it life-changing, while others report little to no benefit.
• 😀 Some studies recommend doses of 10,000+ units of Nattokinase per day, with Vitamin K2 supplementation enhancing its effectiveness in improving cardiovascular health.
• 😀 Nattokinase may interact with blood-thinning medications, and should be avoided by those with soy allergies.
• 😀 Serrapeptase is typically taken on an empty stomach, with potential side effects including gastrointestinal upset.
• 😀 Lumbrokinase has shown promise in improving blood flow, with studies indicating better results when combined with proven anticoagulants.
• 😀 Lumbrokinase has been studied for its effects on stroke prevention and peripheral arterial disease, showing positive results in walking distance and ABI tests.
• 😀 While studies for Nattokinase and Lumbrokinase are promising, there is a lack of large-scale, robust clinical trials, so firm recommendations are not yet possible.
• 😀 Turmeric, which is well-studied, is mentioned as an alternative with proven anticoagulant properties, alongside Nattokinase and Lumbrokinase.

Q & A

What is the main therapeutic use of Nattokinase?

Nattokinase is primarily used as a thrombolytic agent, which means it helps dissolve blood clots. It has shown promise in studies for improving blood flow and reducing clot formation.

What did the study with 1,062 patients reveal about Nattokinase?

The study found that taking 10,800 units of Nattokinase per day significantly improved patient outcomes, especially when combined with Vitamin K2. However, it has been criticized for not being properly conducted, which limits its reliability.

Are there any known side effects or risks associated with Nattokinase?

Potential side effects include interactions with blood-thinning medications and soy allergies. People with soy allergies should avoid Nattokinase, and those on anticoagulant therapy should consult a doctor before using it.

How does Serrapeptase differ from Nattokinase in terms of use and benefits?

Serrapeptase is mainly used for its anti-inflammatory and pain-relief properties, not as a blood thinner. While it may help with conditions like atherosclerosis, there is less robust evidence supporting its cardiovascular benefits compared to Nattokinase.

What are the recommended dosages for Serrapeptase and Nattokinase?

Serrapeptase is typically taken in doses of 10 to 60 milligrams per day, often on an empty stomach. Nattokinase, on the other hand, is commonly taken in doses ranging from 500 to 10,000 units per day, with higher doses showing more promising results in studies.

What does the research say about the effectiveness of Lumbrokinase?

Lumbrokinase has shown promising results in breaking down blood clots and improving blood flow, particularly in patients with conditions like peripheral arterial disease and ischemic strokes. However, the research is still limited and underfunded, so conclusions cannot be definitive.

What are the risks of taking blood-thinning supplements like Serrapeptase, Nattokinase, and Lumbrokinase?

These supplements can interact with blood-thinning medications, such as warfarin or Xarelto. Therefore, anyone on these medications should consult with a doctor before using these enzymes to avoid potential bleeding risks.

What did the study on peripheral arterial disease patients show about Lumbrokinase?

The study showed that Lumbrokinase improved blood flow, as indicated by a better Ankle-Brachial Index (ABI) test. Patients also experienced an improvement in their walking distance, suggesting Lumbrokinase's potential in treating peripheral arterial disease.

Why is Lumbrokinase considered a promising supplement for cardiovascular health?

Lumbrokinase has been shown to improve blood flow and reduce clotting by targeting specific factors. It has demonstrated efficacy in trials, especially when combined with traditional anticoagulants, and has resulted in better outcomes for stroke prevention and peripheral arterial disease.

What is the major limitation of the studies on Serrapeptase, Nattokinase, and Lumbrokinase?

The major limitation is the lack of large-scale, high-quality clinical trials. Many of the studies on these enzymes are underfunded, and while promising, the results are not robust enough to make definitive recommendations for widespread use.